(Q37738720)

22 August 2017

1 reference

title

Insulin, insulin resistance, obesity, and cancer (English)

1 reference

22 August 2017

0 references

1 reference

1 reference

2

Derek LeRoith

1 reference

22 August 2017

Emily Jane Gallagher

1

1 reference

22 August 2017

1 April 2010

1 reference

22 August 2017

Current diabetes report

1 reference

22 August 2017

10

1 reference

22 August 2017

2

1 reference

22 August 2017

93-100

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-010-0101-y

22 August 2017

0 references

cites work

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0101-Y

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0101-Y

The insulin-like growth factor system and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0101-Y

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-010-0101-Y

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer

21 January 2018

1 reference

12 December 2020

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

1 reference

12 December 2020

Obesity and risk of cancer in Japan

1 reference

12 December 2020

Prevalence of overweight and obesity in the United States, 1999-2004

1 reference

12 December 2020

Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer

1 reference

12 December 2020

Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans

1 reference

12 December 2020

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

12 December 2020

Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.

1 reference

12 December 2020

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

1 reference

12 December 2020

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study

1 reference

12 December 2020

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner

1 reference

12 December 2020

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

12 December 2020

Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis.

1 reference

12 December 2020

Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth

1 reference

12 December 2020

Cancer statistics, 2009

1 reference

12 December 2020

Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies

1 reference

12 December 2020

Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

12 December 2020

Neonatal diabetes mellitus

1 reference

12 December 2020

A prospective study of plasma C-peptide and colorectal cancer risk in men

1 reference

12 December 2020

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

1 reference

12 December 2020

Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors

1 reference

12 December 2020

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

1 reference

12 December 2020

Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study

1 reference

12 December 2020

Fasting serum glucose level and cancer risk in Korean men and women

1 reference

12 December 2020

The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models

1 reference

12 December 2020

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

1 reference

12 December 2020

Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis

1 reference

12 December 2020

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

1 reference

12 December 2020

Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways

1 reference

12 December 2020

Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC)

1 reference

12 December 2020

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

12 December 2020

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

12 December 2020

Two variants on chromosome 17 confer prostate cancer risk and the one in TCF2 protects against type 2 diabetes

1 reference

12 December 2020

Probability of pancreatic cancer following diabetes: a population-based study

1 reference

12 December 2020

Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States)

1 reference

12 December 2020

Association of obesity and cancer risk in Canada

1 reference

12 December 2020

Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies

1 reference

12 December 2020

Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis

1 reference

12 December 2020

Cellular actions of the insulin-like growth factor binding proteins

1 reference

12 December 2020

Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression

1 reference

12 December 2020

Novel insulin analogues and its mitogenic potential

1 reference

12 December 2020

A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk

1 reference

12 December 2020

A meta-analysis of diabetes mellitus and the risk of prostate cancer

1 reference

12 December 2020

Metabolic abnormalities and risk for colorectal cancer in the physicians' health study

1 reference

12 December 2020

1 reference

12 December 2020

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

12 December 2020

Long-term mortality after gastric bypass surgery

1 reference

12 December 2020

Diabetes and risk of endometrial cancer: a population-based prospective cohort study

1 reference

12 December 2020

Metformin in breast cancer: time for action

1 reference

12 December 2020

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

1 reference

12 December 2020

Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan

1 reference

12 December 2020

Overweight as an avoidable cause of cancer in Europe.

1 reference

12 December 2020

Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer

1 reference

12 December 2020

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

1 reference

12 December 2020

10.1007/S11892-010-0101-Y

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20425567